Research programme: cannabinoid receptor CB1 antagonists - Esteve

Drug Profile

Research programme: cannabinoid receptor CB1 antagonists - Esteve

Alternative Names: E-6776

Latest Information Update: 15 Jun 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Esteve
  • Class Small molecules
  • Mechanism of Action Cannabinoid receptor CB1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Obesity; Smoking withdrawal

Most Recent Events

  • 15 Jun 2005 Preclinical trials in Smoking withdrawal in Spain (unspecified route)
  • 18 Mar 2005 Preclinical trials in Obesity in Spain (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top